Literature DB >> 34032895

Esophageal dysmotility and lung disease in patients with systemic sclerosis: is there a possible association or correlation? A retrospective chart review.

Navya Kuchipudi1, Shweta Kishore2, Chia-Ling Kuo3, Santhanam Lakshminarayanan4,5, Ranadeep Mandhadi6.   

Abstract

OBJECTIVE: Our aim was to evaluate the relationship between esophageal dysmotility and lung disease by correlating the results of Echocardiogram and Pulmonary Function Test (PFT) with Esophageal Transit Study (ETT).
METHODS: Charts of Systemic Sclerosis (SSc) patients fulfilling 2013 ACR/EULAR classification criteria seen in Rheumatology clinics were reviewed and their demographics, ETT result, PFT, and echocardiogram data were collected at baseline, years 1, 3, 5, and 10. Patients were divided based on their ETT status and were compared with respect to each variable using a two-sided two-sample t test for continuous variables and a Fisher's exact test for categorical variables.
RESULTS: 130 patients were identified with either limited cutaneous SSc (109) or diffuse cutaneous SSc (21) with a mean age of 52.65 years. The mean DLCO was statistically worse in abnormal ETT patients [p value = 0.0004] as were the progression rates per year for DLCO at - 2.25 (p value = 0.019). Progression rate of FVC per year was statistically significant in the abnormal ETT group, although the mean value was not. The number of patients with abnormal PASP was not statistically different between the two groups (p values 0.104, 0.178, 0.653 at baseline, years 3 and 5, respectively).
CONCLUSION: The presence of esophageal dysmotility was associated with increased pulmonary involvement in the form of abnormal DLCO with worsening progression rates per year. There was no statistically significant difference in PASP and FVC between the two groups; however, the progression rate for FVC was worse in adjusted models.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Esophageal dysmotility; Interstitial lung disease; Pulmonary artery hypertension; Pulmonary function test; Systemic sclerosis

Mesh:

Year:  2021        PMID: 34032895     DOI: 10.1007/s00296-021-04880-w

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  2 in total

Review 1.  Gastrointestinal Motility, Part 1: Esophageal Transit and Gastric Emptying.

Authors:  Alan H Maurer
Journal:  J Nucl Med       Date:  2015-05-29       Impact factor: 10.057

Review 2.  Assessment of pulmonary artery pressure by echocardiography-A comprehensive review.

Authors:  Sathish Parasuraman; Seamus Walker; Brodie L Loudon; Nicholas D Gollop; Andrew M Wilson; Crystal Lowery; Michael P Frenneaux
Journal:  Int J Cardiol Heart Vasc       Date:  2016-07-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.